Public Profile

Sandoz A/S

Sandoz A/S, a prominent player in the pharmaceutical industry, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 1886, Sandoz has established itself as a leader in generic pharmaceuticals and biosimilars, focusing on high-quality, affordable medicines that enhance patient access to essential treatments. The company’s core offerings include a diverse range of generic medications, biosimilars, and over-the-counter products, distinguished by their rigorous quality standards and innovative approaches. Sandoz is recognised for its commitment to sustainability and patient-centric solutions, positioning itself as a trusted partner in healthcare. With a strong market presence and a history of significant milestones, Sandoz A/S continues to drive advancements in the pharmaceutical sector, making a meaningful impact on global health.

DitchCarbon Score

How does Sandoz A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Sandoz A/S's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Sandoz A/S's reported carbon emissions

Sandoz A/S, headquartered in Denmark (DK), currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate pledges outlined in their initiatives. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, as a player in the pharmaceutical industry, Sandoz is likely to be influenced by broader industry trends towards sustainability and emissions reduction. The company may be expected to align with global efforts to mitigate climate change, although specific actions or targets remain unspecified at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sandoz A/S's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sandoz A/S is in DK, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sandoz A/S is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Dr Reddys Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

AbZ-Pharma GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Aliud Pharma GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

1 A Pharma GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers